He focuses on the third receptor retatrutide targets and claims it drives fat burning through the liver. His explanation, not a trial finding.
Recap by typeshit. Post by @josh.holyfield on Instagram.
A short post credits scientists with finding axolotl peptides that kill breast cancer cells. It names no study or team, so treat it as an early claim.
Pratt, a psychology professor who studies the circuits behind food motivation, walks through what neuroscience shows about these drugs.
Lilly's pill had major heart events in 4.2% of patients vs 5.0% on insulin glargine. The Clinical Trial Vanguard argues rivals now need to show benefit, not just safety.
Researchers report that asprosin, a hunger hormone released by fat tissue, stays elevated after weight loss, which could help explain why lost pounds come back.
An indirect comparison found 1.46 points more weight loss than 25 mg Rybelsus at 52 weeks. GlobalData's analyst says head-to-head trials are still needed.
In a 39-person randomized pilot, people on the support programs regained about 3.6% of body weight in four months, versus roughly 11% with usual care.
Loading…